Biotech giant's shares dive after CEO's shock departure Shares in Australia's largest biopharmaceutical company have hit an eight-year low after the sudden retirement of its chief executive. AAP · Feb 10
'Didn't have the skills': biotech boss retires abruptly A desire for new leadership has been cited as a reason for the sudden retirement of the head of an $89 billion biopharmaceutical company. AAP · Feb 10
Konstantin Grigorishin: Why Team-Based Formats Resonate with Modern Sports Fans Sport has always been about more than results. At its core, fan engagement is shaped by emotional connection, identity, and continuity over time. inkl · Feb 3
Australian shares slip as energy, IT stocks fall Energy and IT stocks have led the bourse lower in 2025's third-last trading session, anchored by weakness in the heavyweight financials and materials sectors. AAP · Dec 29, 2025
CSL injects $2.3b into US for valuable blood plasma After Donald Trump threatened pharmaceutical tariffs, CSL says it will invest another $2.3 billion building a new blood plasma facility in the United States. AAP · Nov 18, 2025
Australians are boozing less, getting fewer flu jabs and choosing home brands: five things we learned from AGM season Companies offer some surprising insights into changing consumer trends at annual shareholder meetings The Guardian - AU · Oct 31, 2025
Deposit return scheme blocked after issue became ‘politicised’, court told Waste management firm Biffa is suing the Scottish Government for £51.4 million, following the decision to delay the proposed scheme. Evening Standard · Oct 30, 2025
Government assurances on deposit return ‘foundational’ to investment, says Biffa The waste management firm is suing the Scottish Government for £51.4 million after the recycling initiative was delayed. Evening Standard · Oct 30, 2025
CSL share price plummets amid shareholder revolt over executive pay plans US vaccination forecast leads to fall in stock price, while board survives spill in ‘second strike’ over pay concerns at AGM The Guardian - AU · Oct 28, 2025
CSL shares plunge to six-year low as growth stalls CSL shares have tumbled more than 15 per cent to their lowest level since 2018 after it cut its profit forecast given falling US flu vaccine rates. AAP · Oct 28, 2025
Aussie shares fall as miners, major companies drag A strong banking sector performance wasn't enough to rescue Australia's share market from a negative session, as miners and two segment leaders tumbled. AAP · Oct 28, 2025
Australian executives don’t deserve big bonuses. It’s time to end the cult of the CEO Hardly anyone now believes in the neoliberal myth that giving more money to already highly paid executives leads to better companies The Guardian - AU · Oct 23, 2025
CSL and Optus pay millions to executives despite paying no company tax in Australia Biotech company argues high pay is required to retain and attract ‘world-class’ talent The Guardian - AU · Oct 21, 2025
Optus among companies earning billions in Australia but paying no income tax Latest ATO report reveals string of mostly multinational firms continue to be able to pay no or very little income tax, including Netflix, Apple and Microsoft The Guardian - AU · Oct 3, 2025
AAP · Sep 26, 2025 Australia to cop deeper impact from new US meds tariffs The US plan to slap new tariffs on pharmaceutical drugs will likely have a chilling effect on Australia's pharmaceutical export sector, a think tank says.
AAP · Sep 26, 2025 Aussie pharma giant sees no pain from big Trump tariffs The Australian government and pharmaceutical exporters are scrambling to determine whether they will be impacted by Donald Trump's latest tariff bombshell.
AAP · Sep 16, 2025 Aussie shares follow Wall Street to finish in the green Anticipation of rate cuts in the Unites States has buoyed Wall Street traders, with the positive outlook flowing onto the Australian share market.
AAP · Sep 15, 2025 CSL in $757m deal with pioneering Dutch biotech CSL is paying to partner with a Dutch company developing an emergency treatment for patients on blood thinners who experience uncontrolled bleeding.
AAP · Sep 8, 2025 Aussie stocks down as September sell-down continues Australian shares have begun the week lower, led by banks and energy stocks as gold hovers near record highs.
AAP · Aug 19, 2025 Biotech giant to slash 3000 jobs, spin-off vaccine arm Pharmaceutical giant CSL has announced a major shake-up for its vaccination arm and for jobs as the company aims to cut costs.
The Conversation · Jul 10, 2025 Trump has flagged 200% tariffs on Australian pharmaceuticals. What do we produce here, and what’s at risk? US President Donald Trump’s proposed tariffs on Australia’s pharmaceutical exports to the United States has raised alarm among industry and government leaders.
The Guardian - AU · Apr 3, 2025 Labor offers $1bn in loans to Australian export companies and seeks to loosen US trade ties after Trump tariffs Federal government unveils protective measures to help export-focused companies tap alternative markets
International Business Times · Mar 19, 2025 US Pharma Lobby Targets Australia's AU$18B PBS, Urges Trump To Impose Punitive Tariffs On March 11, a formal complaint was submitted to US Trade Representative Jamieson Greer, urging the Trump administration to take strong action against Australia's "damaging pricing policies."
AAP · Feb 10, 2025 Drop in immunisation rates hits vaccine-maker's revenue Sales of CSL's flu vaccines were down by double digits in the first half amid a fall in immunisation rates since the COVID-19 pandemic.
The Guardian - UK · Jan 1, 2025 Eight years, three league titles and lots of money: how Oscar made a success of China stay The Brazilian, in contrast to many other footballers, embraced living in China with his family and will be sorely missed